CRL vs MATX · rev $2.00B vs P/E 7.5, rev $1.73B
Charles River Laboratories (CRL) versus Matson Inc (MATX) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Matson Inc (MATX) is a marine shipping company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MATX revenue for 2026-06-30 was $1.73B. Net income was $186.0M. MATX currently screens at market cap $3.69B and trailing P/E 7.5.
CRL currently screens at market cap $7.78B. MATX currently screens at market cap $3.69B and trailing P/E 7.5.
Not investment advice. Open the CRL and MATX stock pages for the full models.
Not investment advice.